In the ANIT-induced cholestasis model, transport from hepatocytes to bile duct and to systemic circulation was enhanced, and reabsorption of bile acid mediated by NTCP was inhibited, while MBT1805 significantly reversed the abnormal expression of bile acid transport. Here, SLC10A1 is linked to cholestasis.